Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
1,140
Total Claims
$789K
Drug Cost
149
Beneficiaries
$5,297
Cost/Patient
Risk Score Breakdown 43/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+1228%
Opioid rate vs peers
83.3% vs 6.3% avg
-61%
Cost per patient vs peers
$5,297 vs $14K avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 1,228% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
83.3%
Opioid Rate
950
Opioid Claims
$47K
Opioid Cost
21.4%
Long-Acting Rate
This provider's opioid prescribing rate of 83.3% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 0 claims · $0
Generic: 924 claims · $41K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Voxelotor | 32 | $398K |
| Crizanlizumab-Tmca | 15 | $178K |
| Oxycodone Myristate | 23 | $16K |
| Oxycodone Hcl | 20 | $11K |
| Hydrocodone/Acetaminophen | 379 | $8,427 |
| Morphine Sulfate | 147 | $3,932 |
| Oxycodone Hcl | 129 | $3,028 |
| Epoetin Alfa-Epbx | 11 | $2,424 |
| Oxycodone Hcl/Acetaminophen | 62 | $2,180 |
| Morphine Sulfate | 60 | $1,613 |
| Hydroxyurea | 37 | $1,530 |
| Hydromorphone Hcl | 105 | $1,343 |
| Methadone Hcl | 12 | $293 |
| Tramadol Hcl | 11 | $87 |
Prescribing Profile
12
Unique Drugs
43.0
Anomaly Score
Patient Profile
45
Avg Age
65%
Female
4.87
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About